StockData
Azitra, Inc. logo

Azitra, Inc. (AZTR) stock

AZTRNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$0.57−0.04 (-6.20%)

Close on Nov 18, 2026Market cap $34.56MP/E –Yield –

Azitra net income

Net income is the profit left for shareholders after every expense, interest and tax.

Azitra's net income for the twelve months ending Jun 30, 2026 was -$12.27M. For fiscal 2025 it was -$10.96M.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$10.96M–
FY2024Dec 31, 2024-$8.97M–
FY2023Dec 31, 2023-$11.28M–
FY2022Dec 31, 2022-$10.68M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.35M–
Q1 FY2026Mar 31, 2026-$3.93M–
Q4 FY2025Dec 31, 2025-$2.23M–
Q3 FY2025Sep 30, 2025-$2.76M–
Q2 FY2025Jun 30, 2025-$2.89M–
Q1 FY2025Mar 31, 2025-$3.07M–
Q4 FY2024Dec 31, 2024-$2.39M–
Q3 FY2024Sep 30, 2024-$1.01M–
Q2 FY2024Jun 30, 2024-$2.63M–
Q1 FY2024Mar 31, 2024-$2.93M–
Q4 FY2023Dec 31, 2023-$2.45M–
Q3 FY2023Sep 30, 2023-$1.94M–
Q2 FY2023Jun 30, 2023-$4.43M–
Q1 FY2023Mar 31, 2023-$2.46M–
Q4 FY2022Dec 31, 2022-$4.05M–
Q3 FY2022Sep 30, 2022-$2.42M–
Q2 FY2022Jun 30, 2022-$1.89M–
Q1 FY2022Mar 31, 2022-$2.33M–

More Azitra figures

See a number that looks wrong?